Hidradenitis secondary to nirogacestat, a recently approved desmoid tumor medication
Saved in:
Main Authors: | Travis C. Frantz, MD, David Kirwin, MD, Catherine Brahe, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | JAAD Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512624005137 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hidradenitis Suppurativa-Like Tuberculosis: A Warning for Dermatologists
by: Jose Paulo Ribeiro Junior, et al.
Published: (2025-01-01) -
Hidradenitis suppurativa induced by ipilimumab and nivolumab: A rare association
by: Alexander D. Woods, MD, et al.
Published: (2025-03-01) -
Secukinumab Treatment in Patients With Hidradenitis Suppurativa in Real-World Clinical Settings: A Multicenter Study
by: Ece Erbağcı, et al.
Published: (2025-01-01) -
Immediate versus Delayed Wound Closure in Hidradenitis Suppurativa Surgery: A Comparative Outcomes Study
by: Ehud Fliss, et al. -
Acquired Lymphangioma Circumscriptum of Vulva in a Patient With Hidradenitis Suppurativa: A Rare Case at a Rare Site
by: Ranju Pokharel, et al.
Published: (2025-01-01)